Biden administration moves to limit nicotine in cigarettes and certain other tobacco products
The US Food and Drug Administration is proposing limits on the level of nicotine in cigarettes and some other types of ...
New rule could slash nicotine levels in tobacco products
The Biden administration is poised to try to lower the amount of nicotine in tobacco products, an eleventh-hour effort that’s ...
3 Reasons to Buy British American Tobacco Stock Like There's No Tomorrow
Despite persistent regulatory uncertainty and declining cigarette usage worldwide, the tobacco industry is alive and well in ...
‘Unsafe’: Mass. communities change approach on who can buy nicotine, tobacco products
Federal law clearly states that someone must be 21 years old to buy tobacco or other nicotine products. Some Massachusetts ...
Zyn nicotine pouches get FDA approval
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
FDA proposes sweeping limits on nicotine in cigarettes
The Food and Drug Administration (FDA) released a sweeping proposal Wednesday to try to make cigarettes less addictive by ...
Biden releases 11th-hour plan to lower nicotine in cigarettes
The proposal in the waning days of the Biden administration leaves it up to President-elect Donald Trump to finalize the ...
STAT1d
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
The war on smoking turns to cigarettes with ultralow nicotine
The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.
Convenience Store News16h
Latest Rule to Cap Nicotine in Cigarettes Prompts Mixed Responses
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...